文献速递临床试验与 GCP流行病学与生物统计

经尿道膀胱肿瘤电切术的手术质量影响了一项比较钥孔戚血蓝蛋白与丝裂霉素C的III期试验

Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C.
PubMed 文献 · Trials · 2017-03-14

该研究基于一项在18家医院纳入553例患者的随机试验数据,比较钥孔戚血蓝蛋白(KLH)与丝裂霉素C(MM)的疗效。按中心分层分析显示,18家医院中6家log-rank检验P<0.05、12家P>0.05。KLH组不同医院组的中位无复发生存期(RFS)差异有统计学意义(P=0.03),而MM组无统计学意义(P=0.05)。结论认为中心效应在KLH组更明显,可能因医生经尿道膀胱肿瘤电切术(TURBT)经验差异造成混杂。

要点

  • 18家医院中6家疗效比较P<0.05,12家P>0.05,患者数与P值无关联。
  • KLH组不同医院组中位RFS差异有统计学意义(P=0.03),MM组无统计学意义(P=0.05)。
  • 医生TURBT手术经验可能造成中心效应,影响多中心试验疗效判断。

核心结论

  • KLH组中位RFS的中心效应较MM组更明显。
  • 存在此类非产品相关中心效应时,得出一种药物优于另一种的结论可能产生混杂偏倚。
  • 该试验中医生既往TURBT经验可能促成了评估KLH与MM疗效时的中心效应。

研究设计与样本

  • 对一项在18家医院开展的随机试验数据进行回顾性中心效应分析。
  • 共纳入553例患者,KLH组283例,MM组270例。

主要发现

  • 按医院逐中心进行log-rank检验,18家医院中6家P<0.05,其余12家P>0.05。
  • 各医院分析患者数与对应P值之间未观察到关联。
  • 将患者数据合并为6家医院组与12家医院组后,KLH组中位RFS差异有统计学意义(P=0.03)。
  • MM组相应中位RFS差异无统计学意义(P=0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Retrospective analysis of Center effect of the multi-center trial conducted to compare Immucothel (KLH Immunotherapy drug product) with Mytomycin-C (MM) concluded that efficacy evaluation of the drug product may be impacted by physician's subjective performance of Transurethral resection of bladder tumor (TURBT). METHODS: A randomized trial was performed in 18 hospitals (clinical centers) and a total of 553 recruited, 283 patients under KLH arm and 270 patients under MM. An initial statistical analysis of efficacy comparisons between KLH and MM based on log-rank test performed for each center (hospital) showed 6 hospitals out of 18 hospitals a p-value of <0.05 and remaining 12 hospitals showed a p-values of >0.05. No association was observed between number of patients analysed and the associated p-values across hospitals. Final statistical analyses were carried out under each drug product using Kaplan-Meier survival analysis along with log-rank test after combining all eligible patients data for 6 hospital group and 12 hospital group. RESULTS: Median recurrence free survival (RFS) times (in weeks) showed statistical significance (p-value = 0.03) between two groups of hospitals under KLH arm, while similar median values showed no statistical significance (p-value = 0.05). CONCLUSION: Center effect with respect to median RFS values under KLH was more pronounced than under MM. Under the presence of such center effect, for reasons other than product related effects, concluding superiority of one drug product over another may create confounding bias conclusions in multi-center clinical trials. In the above cited clinical trial study, physician's prior experience on TURBT might have contributed to center effect in examining efficacies of KLH and MM. Similar observation was also noted in the literature on studies dealing with TURBT and in other clinical studies. TRIAL REGISTRATION: Data set used in this study is based on previously documented clinical trial in the literature: See (Lammers et al., J Clin Oncol 30:2273-9, 2012) and Acknowledgments.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Prasad NN, Muddukrishna SN. Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C. Trials. 2017. PMID: 28292319. doi:10.1186/s13063-017-1843-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。